Deborah H. Telman, Director of AtriCure ATRC, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $6.6M. The latest trade was on 05/18.

DT

DT

Deborah H. Telman

Director

Company

AtriCure ATRC

First filing

23/02/23

Trades

79 trades

Buys / sales

0 / 3

12-month net buying

−$6.6M

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Gilead SciencesGILD	Open-market sale10b5-1 plan	25/11/12	25/11/13	53,646 sh3 trades	$122.85avg.	$6,590,413.5	−55.1%